HomeNewsOpinionRichcore Lifesciences acquisition marks successful diversification for Laurus Labs, scale-up key

Richcore Lifesciences acquisition marks successful diversification for Laurus Labs, scale-up key

R. Sree Ram • December 02, 2020 / 10:29 IST

Acquisition of Richcore Lifesciences will give Laurus Labs a foothold in the growing biotechnology sector. Scale-up of the business can be time consuming but can yield meaningful earnings benefits

To read the full story,

Are you a PRO subscriber? Sign In

Ad free Experience

Seamless navigation, faster responses.
Expert Perspective

Explore 230+ exclusive editorials every month
+

Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights

40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events

Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters

Stay ahead with daily and weekly insights

Unlock exclusive discounts